Updated perspectives on the cytosolic sulfotransferases (SULTs) and SULT-mediated sulfation

被引:70
作者
Suiko, Masahito [1 ]
Kurogi, Katsuhisa [1 ,2 ]
Hashiguchi, Takuyu [1 ]
Sakakibara, Yoichi [1 ]
Liu, Ming-Cheh [2 ]
机构
[1] Miyazaki Univ, Dept Biochem & Appl Biosci, Fac Agr, Miyazaki, Japan
[2] Univ Toledo, Dept Pharmacol, Coll Pharm & Pharmaceut Sci, 2801 W Bancroft St, Toledo, OH 43606 USA
基金
日本学术振兴会; 美国国家卫生研究院;
关键词
sulfotransferase; 3-phosphoadenosine-5-phosphosulfate; Phase II; detoxifying enzymes; CATECHOL-O-METHYLTRANSFERASE; MOLECULAR-CLONING; THYROID-HORMONE; FUNCTIONAL-CHARACTERIZATION; HUMAN FETAL; ESTROGEN SULFOTRANSFERASE; CDNA CLONING; HYDROXYSTEROID SULFOTRANSFERASES; TISSUE DISTRIBUTION; OXIDATIVE STRESS;
D O I
10.1080/09168451.2016.1222266
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cytosolic sulfotransferases (SULTs) are Phase II detoxifying enzymes that mediate the sulfate conjugation of numerous xenobiotic molecules. While the research on the SULTs has lagged behind the research on Phase I cytochrome P-450 enzymes and other Phase II conjugating enzymes, it has gained more momentum in recent years. This review aims to summarize information obtained in several fronts of the research on the SULTs, including the range of the SULTs in different life forms, concerted actions of the SULTs and other Phase II enzymes, insights into the structure-function relationships of the SULTs, regulation of SULT expression and activity, developmental expression of SULTs, as well as the use of a zebrafish model for studying the developmental pharmacology/toxicology.
引用
收藏
页码:63 / 72
页数:10
相关论文
共 122 条
[1]   Interindividual variability in acetaminophen sulfation by human fetal liver: Implications for pharmacogenetic investigations of drug-induced birth defects [J].
Adjei, Araba A. ;
Gaedigk, Andrea ;
Simon, Stephen D. ;
Weinshilboum, Richard M. ;
Leeder, J. Steven .
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2008, 82 (03) :155-165
[2]   HUMAN LIVER ESTROGEN SULFOTRANSFERASE - IDENTIFICATION BY CDNA CLONING AND EXPRESSION [J].
AKSOY, IA ;
WOOD, TC ;
WEINSHILBOUM, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 200 (03) :1621-1629
[3]   Coordinated Regulation of Hepatic Phase I and II Drug-Metabolizing Genes and Transporters using AhR-, CAR-, PXR-, PPARα-, and Nrf2-Null Mice [J].
Aleksunes, Lauren M. ;
Klaassen, Curtis D. .
DRUG METABOLISM AND DISPOSITION, 2012, 40 (07) :1366-1379
[4]   Structural and chemical profiling of the human cytosolic sulfotransferases [J].
Allali-Hassani, Abdellah ;
Pan, Patricia W. ;
Dombrovski, Ludmila ;
Najmanovich, Rafael ;
Tempel, Wolfram ;
Dong, Aiping ;
Loppnau, Peter ;
Martin, Fernando ;
Thonton, Janet ;
Edwards, Aled M. ;
Bochkarev, Alexey ;
Plotnikov, Alexander N. ;
Vedadi, Masoud ;
Arrowsmith, Cheryl H. .
PLOS BIOLOGY, 2007, 5 (05) :1063-1078
[5]   Regulation of sulfotransferase enzymes by prototypical microsomal enzyme inducers in mice [J].
Alnouti, Yazen ;
Klaassen, Curtis D. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 324 (02) :612-621
[6]   Cloning and sequencing of the Klebsiella K-36 astA gene, encoding an arylsulfate sulfotransferase [J].
Baek, MC ;
Kim, SK ;
Kim, DH ;
Kim, BK ;
Choi, EC .
MICROBIOLOGY AND IMMUNOLOGY, 1996, 40 (08) :531-537
[7]   DEHYDROEPIANDROSTERONE SULFOTRANSFERASE IN THE DEVELOPING HUMAN FETUS - QUANTITATIVE BIOCHEMICAL AND IMMUNOLOGICAL CHARACTERIZATION OF THE HEPATIC, RENAL, AND ADRENAL ENZYMES [J].
BARKER, EV ;
HUME, R ;
HALLAS, A ;
COUGHTRIE, MWH .
ENDOCRINOLOGY, 1994, 134 (02) :982-989
[8]  
Baumann E., 1876, Ber. Dtsch. Chem. Ges., V9, P54, DOI [DOI 10.1002/(ISSN)1099-0682, DOI 10.1002/CBER.18760090121]
[9]   Enzymatic mechanisms involved in phenanthrene degradation by the white rot fungus Pleurotus ostreatus [J].
Bezalel, L ;
Hadar, Y ;
Cerniglia, CE .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1997, 63 (07) :2495-2501
[10]   A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily [J].
Blanchard, RL ;
Freimuth, RR ;
Buck, J ;
Weinshilboum, RM ;
Coughtrie, MWH .
PHARMACOGENETICS, 2004, 14 (03) :199-211